Daiwa Securities Group’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4K | Hold |
169
| – | – | ﹤0.01% | 1177 |
|
|
2025
Q1 | $4K | Hold |
169
| – | – | ﹤0.01% | 1153 |
|
|
2024
Q4 | $3K | Hold |
169
| – | – | ﹤0.01% | 1200 |
|
|
2024
Q3 | $3K | Hold |
169
| – | – | ﹤0.01% | 1202 |
|
|
2024
Q2 | $5K | Hold |
169
| – | – | ﹤0.01% | 1194 |
|
|
2024
Q1 | $5K | Hold |
169
| – | – | ﹤0.01% | 1205 |
|
|
2023
Q4 | $6K | Hold |
169
| – | – | ﹤0.01% | 1188 |
|
|
2023
Q3 | $5K | Hold |
169
| – | – | ﹤0.01% | 1156 |
|
|
2023
Q2 | $7K | Hold |
169
| – | – | ﹤0.01% | 1148 |
|
|
2023
Q1 | $7K | Hold |
169
| – | – | ﹤0.01% | 1126 |
|
|
2022
Q4 | $7K | Hold |
169
| – | – | ﹤0.01% | 1126 |
|
|
2022
Q3 | $9K | Hold |
169
| – | – | ﹤0.01% | 1124 |
|
|
2022
Q2 | $10K | Buy |
169
+39
| +30% | +$2.31K | ﹤0.01% | 1134 |
|
|
2022
Q1 | $10K | Hold |
130
| – | – | ﹤0.01% | 1133 |
|
|
2021
Q4 | $8K | Sell |
130
-22
| -14% | -$1.35K | ﹤0.01% | 1156 |
|
|
2021
Q3 | $9K | Buy |
152
+70
| +85% | +$4.15K | ﹤0.01% | 1146 |
|
|
2021
Q2 | $5K | Hold |
82
| – | – | ﹤0.01% | 1070 |
|
|
2021
Q1 | $6K | Hold |
82
| – | – | ﹤0.01% | 1069 |
|
|
2020
Q4 | $5K | Sell |
82
-154
| -65% | -$9.39K | ﹤0.01% | 1054 |
|
|
2020
Q3 | $14K | Hold |
236
| – | – | ﹤0.01% | 1014 |
|
|
2020
Q2 | $8K | Hold |
236
| – | – | ﹤0.01% | 1066 |
|
|
2020
Q1 | $8K | Hold |
236
| – | – | ﹤0.01% | 1063 |
|
|
2019
Q4 | $11K | Sell |
236
-26
| -10% | -$1.21K | ﹤0.01% | 1044 |
|
|
2019
Q3 | $10K | Hold |
262
| – | – | ﹤0.01% | 1022 |
|
|
2019
Q2 | $11K | Hold |
262
| – | – | ﹤0.01% | 1035 |
|
|
2019
Q1 | $10K | Buy |
262
+38
| +17% | +$1.45K | ﹤0.01% | 1023 |
|
|
2018
Q4 | $10K | Hold |
224
| – | – | ﹤0.01% | 988 |
|
|
2018
Q3 | $11K | Hold |
224
| – | – | ﹤0.01% | 1020 |
|
|
2018
Q2 | $7K | Hold |
224
| – | – | ﹤0.01% | 1061 |
|
|
2018
Q1 | $7K | Buy |
+224
| New | +$7K | ﹤0.01% | 1047 |
|